Restarting and timing of oral anticoagulation after traumatic intracranial hemorrhage: a review and summary of ongoing and planned prospective randomized clinical trials

Anticoagulant-associated traumatic intracranial hemorrhage (tICrH) is a devastating injury with high morbidity and mortality. For survivors, treating clinicians face the dilemma of restarting oral anticoagulation with scarce evidence to guide them. Thromboembolic risk is high from the bleeding event...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trauma Surg Acute Care Open
Autors principals: King, Ben, Milling, Truman, Gajewski, Byron, Costantini, Todd W, Wick, Jo, Price, Michelle A, Mudaranthakam, Dinesh, Stein, Deborah M, Connolly, Stuart, Valadka, Alex, Warach, Steven
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7716676/
https://ncbi.nlm.nih.gov/pubmed/33313417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tsaco-2020-000605
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars